Lanean...
FLT3 Inhibition and Mechanisms of Drug Resistance in mutant FLT3-Positive AML
An appealing therapeutic target for AML is constitutively-activated, mutant FLT3, which is expressed in a subpopulation of AML patients and is generally a poor prognostic indicator in patients under the age of 65. There are currently several FLT3 inhibitors that are undergoing clinical investigation...
Gorde:
| Argitaratua izan da: | Drug Resist Updat |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472331/ https://ncbi.nlm.nih.gov/pubmed/19467916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drup.2009.04.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|